A Regentville family is fighting to make life-changing eczema medication Dupilumab more accessible for young Australians. The injection is available on the Pharmaceutical Benefits Scheme (PBS) for Australians aged 12 and over for $25 per month; without that subsidy, it costs $1,600 per month. Seven-year-old Ruby Hlucshniow was granted compassionate access to the injection two years ago following years of excruciating pain. “It was horrendous. I …
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.